Leading Insights

Intrepid Trial Results

Written By: Wendy Ziai, MD, MPH

The results of the INTREPID trial, led by Dr. David Greer, Professor and Chair at Boston University, were announced August 16, 2023 in the Clinical Trials session at the Neurocritical Care Society meeting in Phoenix, Arizona.

Neurocritical care society

Neurocritical Care Insights And
Perspectives From Around the World

Join Our Mailing List

Leading Insights, Pharmacy

The NCS Pharmacy Section: Small in Numbers, Large in Impact

Written By: Jeffrey Mucksavage, PharmD, FNCS, BCPS

The Neurocritical Care Society (NCS) is a diverse and inclusive interprofessional society. This is profoundly reflected in the attitudes of its members and the committee and section structure of the Society. A robust example of the interprofessional culture of the society is its inclusiveness of...

NCS News

Supporting the Future of Neurocritical Care: The Neurocritical Care Foundation Legacy

Written By: Corey Fehnel, MD, MPH, FNCS

Recall a challenging patient who was under your care. Perhaps this was recent, or this is someone who sticks with you from many years ago. These patients drift in and out of my consciousness regularly. Our minds are littered with the memories of patients, their families, the difficult decisions...

Literature Watch

Can Albumin Lower Delayed Cerebral Ischemia in Patients With Subarachnoid Hemorrhage? A New Take on an Old Treatment

Written By: Preethi Ramchand, MD